| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |